ArticleSubstance abuse treatment, prevention, and policy2015
Correlates of public support toward federal funding for harm reduction strategies.
Article in Substance abuse treatment, prevention, and policy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The intersection of gender and drug use-related stigma: A mixed methods systematic review and synthesis of the literature.Drug and alcohol dependence · 2021Pooled it
- Attitudes to Drug Policy in Australia, 2001-2022/23: What Does This Mean for Drug Policy Reform in Australia?Drug and alcohol review · 2026Article
- An experimental investigation of federal messaging on public support for enforcement- and treatment-based approaches for opioid overdose prevention in South Carolina.Health & justice · 2025Article
- Moral foundations underpinning attitudes toward supervised consumption services across Canada's prairie provinces.Harm reduction journal · 2025Article
- Evidence for the efficacy of humanizing narratives to promote support for harm-reduction policies in the United States.Harm reduction journal · 2025Article
- Effectively engaging faith-based leaders on syringe services programs: U.S. pastors' knowledge, perceptions, and questions.Substance abuse treatment, prevention, and policy · 2024Article
- Community Support for Harm Reduction and Treatment of Opioid Use Disorder.Journal of community health · 2024Article
- How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.Harm reduction journal · 2024Article
- Understanding the barriers and facilitators to implementing and sustaining Mobile Overdose Response Services from the perspective of Canadian key interest groups: a qualitative study.Harm reduction journal · 2024Article
- 'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alerts.Harm reduction journal · 2023Article
- A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder.Frontiers in psychiatry · 2023Article
- Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting.Harm reduction journal · 2022Article
- 'It's the same thing as giving them CPR training': rural first responders' perspectives on naloxone.Harm reduction journal · 2022Article
- Differences in the attitudes towards the opioid crisis between metropolitan and rural counties in Central Texas: Secondary data analysis using cross-sectional data.Preventive medicine reports · 2022Article
- Article
- French People's positions on supervised injection facilities for drug users.Substance abuse treatment, prevention, and policy · 2020Article
- Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support.Drug and alcohol dependence · 2017Article
- Towards greater understanding of addiction stigma: Intersectionality with race/ethnicity and gender.Drug and alcohol dependence · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHistorically, US federal policy has not supported harm reduction interventions, such as safe injection facilities (SIFs) and needle and syringe programs (NSPs), which can reduce the burden associated with injection drug use. Given recent increases in abuse of both legal and illegal opioids, there has been a renewed debate about effective ways to address this problem. The current study (1) assessed participants' support for SIFs and NSPs, and (2) evaluated several demographic factors (e.g., age, gender, race, education, political ideology, and religiosity) and individual differences in stigmatizing beliefs about people who inject drugs (PWID) that might relate to support for these interventions.
methodsU.S. adults (N = 899) completed a web-based study that assessed self-reported support for NSPs and SIFs, and stigma about PWID.
resultsThe majority of participants were at least somewhat supportive of both NSPs and SIFs. Regression analyses indicated greater support for NSPs and SIFs was predicted by more liberal political ideology, more agreement that PWID deserve help rather than punishment, older age, and male gender. Also, participants who endorsed lower stigma about PWID were more supportive of NSPs and SIFs. Race, religiosity, and education did not predict support for NSPs and SIFs.
conclusionsMost participants tended to report support for harm reduction strategies. Age, political ideology, and individual differences in stigmatizing beliefs about PWID were significantly associated with support. Given the potential malleability of stigmatizing beliefs, efforts that seek to shift stigma about PWID could have important implications for public policy towards harm reduction strategies for PWID.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.